Apolipoprotein E gene (APOE) genotype in Wilson's disease: Impact on clinical presentation

Parkinsonism and Related Disorders

Volumn 18, Issue 4, 2012, Pages 367-369

  Litwin, T ^a   Gromadzka, G ^a,b   Czlonkowska A ^a,b  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Apolipoprotein E; Genotype; Phenotype; Wilson's disease

Indexed keywords

ADOLESCENT; ADULT; APOLIPOPROTEIN E EPSILON 2 GENE; APOLIPOPROTEIN E EPSILON 3 GENE; APOLIPOPROTEIN E EPSILON 4 GENE; ARTICLE; ATP7B GENE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GENE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; ONSET AGE; PHENOTYPIC VARIATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; WILD TYPE; WILSON DISEASE;

ADENOSINE TRIPHOSPHATASES; ADULT; AGE OF ONSET; ANALYSIS OF VARIANCE; APOLIPOPROTEINS E; CATION TRANSPORT PROTEINS; GENOTYPE; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; MUTATION; PHENOTYPE; PROTEIN ISOFORMS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; YOUNG ADULT;

EID: 84860356867     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.12.005     Document Type: Article

References (15)

1. Pfeiffer R.F. Wilson's disease. Semin Neurol 2007, 27(2):123-132.
2. Roberts E., Schilsky M. Diagnosis and treatment of Wilson's disease an update. Hepatology 2008, 47:2089-2111.
3. Litwin T., Gromadzka G., Czlonkowska A. Gender differences in Wilson's disease. J Neurol Sci 2012, 312:31-35.
4. Stapelbroek J.M., Bollen C.W., van Amstel J.K., Erpecum K.J., van Hattum J., Berg van den L.H., et al. The H1069Q mutation in ATP7B is associated with late and neurologic presentation in Wilson's disease: results of meta-analysis. J Hepatol 2004, 41:758-763.
5. Gromadzka G., Rudnicka M., Chabik G., Przybyłkowski A., Członkowska A. Genetic variability in the methylentetrahydrofolate reductase gene (MTHFR) affects clinical expression of Wilson's diseases. J Hepatol 2011, 55:913-919.
6. Merle U., Stremmel W., Gesner R. Influence of homozygosity for methionine at codon 129 of the human prion gene on the onset of neurological and hepatic symptoms in Wilson's disease. Arch Neurol 2006, 63:982-985.
7. Gromadzka G., Czlonkowska A. Influence of IL-1RN intron 2 variable number of tandem repeats (VNTR) polymorphism on the age at onset of neuropsychiatric symptoms in Wilson's disease. Int J Neurosci 2011, 121:8-15.
8. Verghese P.B., Castellano J.M., Holtzman D.M. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol 2011, 10:241-252.
9. Schiefermeier M., Kolleger H., Madl C., Polli C., Oder W., Kühn H., et al. The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease. Brain 2000, 123:585-590.
10. Wang X.P., Wang X.H., Bo Y.C., Zhou J.N. Apolipoprotein E genotypes in Chinese patients with Wilson's disease. Q J Med 2003, 96:541-544.
11. Kocabay G., Tutuncu Y., Yilmaz H., Demir K. Impact of apolipoprotein E genotypes on phenotypic expression in Turkish patients with Wilson's disease. Scand J Gastroenterol 2009, 44:1270-1271.
12. Gu Y.H., Kodama H., Du S.L. Apolipoprotein E genotype analysis in Chinese Han ethnic children with Wilson's disease, with a concentration on those homozygous for R778L. Brain Dev 2005, 27:551-553.
13. Kesaniemi Y.A., Ehnholm C., Miettinen T.A. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 1987, 80:578-581.
14. Corpechot C., Benlian P., Barbu V., Chazouilleres O., Poupon R.E., Poupon R. Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis. J Hepatol 2001, 35:324-328.
15. Srivastava R.A., Srivastava N., Averna M., Lin R.C., Korach K.S., Lubahn D.B., et al. Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing apoE mRNA in the translating pool via the estrogen receptor alfa-mediated pathway. J Biol Chem 1997, 272(52):33360-33366.